Hiroki Yoshida

1.8k total citations · 1 hit paper
39 papers, 1.5k citations indexed

About

Hiroki Yoshida is a scholar working on Epidemiology, Pharmacology and Geriatrics and Gerontology. According to data from OpenAlex, Hiroki Yoshida has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Pharmacology and 8 papers in Geriatrics and Gerontology. Recurrent topics in Hiroki Yoshida's work include Pharmacy and Medical Practices (9 papers), Pharmaceutical Practices and Patient Outcomes (8 papers) and Safe Handling of Antineoplastic Drugs (7 papers). Hiroki Yoshida is often cited by papers focused on Pharmacy and Medical Practices (9 papers), Pharmaceutical Practices and Patient Outcomes (8 papers) and Safe Handling of Antineoplastic Drugs (7 papers). Hiroki Yoshida collaborates with scholars based in Japan, Brazil and Mongolia. Hiroki Yoshida's co-authors include Masahiko Kurokawa, Hiroyuki Mori, Ichiko Kinjyo, Wataru Watanabe, Daisuke Aki, Kyoko Inagaki‐Ohara, Masato Kubo, Akihiko Yoshimura, Masanobu Ohishi and Toshikatsu Hanada and has published in prestigious journals such as Journal of Biological Chemistry, Immunity and Biochemical and Biophysical Research Communications.

In The Last Decade

Hiroki Yoshida

35 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SOCS1/JAB Is a Negative Regulator of LPS-Induced Macrophage Activation

2002 540 citations Hiroki Yoshida et al. profile →

Peers

Countries citing papers authored by Hiroki Yoshida

Since Specialization

Citations

This map shows the geographic impact of Hiroki Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Yoshida more than expected).

Fields of papers citing papers by Hiroki Yoshida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Yoshida. The network helps show where Hiroki Yoshida may publish in the future.

Co-authorship network of co-authors of Hiroki Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Yoshida. A scholar is included among the top collaborators of Hiroki Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Yoshida. Hiroki Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of Bovine Lactoferrin on the Maintenance of Respiratory and Systemic Physical Conditions in Healthy Adults—A Randomized, Double-Blind, Placebo-Controlled Trial 2023 ·Nutrients ·Hirotsugu Oda, (unknown), (unknown), (unknown), Chihiro Sugita, Hiroki Yoshida, (unknown), Miyuki Tanaka, Masahiko Kurokawa	6
2	Preventive and Ameliorating Effects of Food Factors on Obesity-related Diseases by Regulating Inflammation 2021 ·YAKUGAKU ZASSHI ·Hiroki Yoshida	0
3	Effect of inactivated Streptococcus pneumoniae as non-pathogenic particles on the severity of pneumonia caused by respiratory syncytial virus infection in mice 2019 ·Toxicology Reports ·(unknown), Wataru Watanabe, (unknown), (unknown), Hiroki Yoshida, Chihiro Sugita, Masahiko Kurokawa	2
4	Naringenin interferes with the anti-diabetic actions of pioglitazone via pharmacodynamic interactions 2016 ·Journal of Natural Medicines ·Hiroki Yoshida, (unknown), Toshiyuki Atsumi, (unknown), Wataru Watanabe, Chihiro Sugita, Masahiko Kurokawa	16
5	Augmentation of T helper type 1 immune response through intestinal immunity in murine cutaneous herpes simplex virus type 1 infection by probiotic Lactobacillus plantarum strain 06CC2 2016 ·International Immunopharmacology ·(unknown), Shiro Takeda, Masahiko Takeshita, (unknown), (unknown), (unknown), Chihiro Sugita, Hiroki Yoshida, Wataru Watanabe, Masahiko Kurokawa	28
6	Titanium dioxide nanoparticles exacerbate pneumonia in respiratory syncytial virus (RSV)-infected mice 2015 ·Environmental Toxicology and Pharmacology ·(unknown), Hiroki Yoshida, (unknown), (unknown), Tomoyuki Ueda, Yoshiaki Ikarashi, (unknown), Katsuhiko Konno, (unknown), Akihiko Hirose, Masahiko Kurokawa, Wataru Watanabe	19
7	Naringenin suppresses macrophage infiltration into adipose tissue in an early phase of high-fat diet-induced obesity 2014 ·Biochemical and Biophysical Research Communications ·Hiroki Yoshida, Hideaki Watanabe, Akiko Ishida, Wataru Watanabe, (unknown), Toshiyuki Atsumi, Chihiro Sugita, Masahiko Kurokawa	58
8	Effects of Oral Administration of Probiotics from Mongolian Dairy Products on the Th1 Immune Response in Mice 2013 ·Bioscience Biotechnology and Biochemistry ·(unknown), Satoshi Kawahara, Muneaki Hidaka, Hiroki Yoshida, Wataru Watanabe, Masahiko Takeshita, Yukiharu Kikuchi, Bumbein Dashnyam, Michio Muguruma, Masahiko Kurokawa	24
9	Effect of Brazilian Propolis on Exacerbation of Respiratory Syncytial Virus Infection in Mice Exposed to Tetrabromobisphenol A, a Brominated Flame Retardant 2013 ·Evidence-based Complementary and Alternative Medicine ·(unknown), Wataru Watanabe, (unknown), Yuya Hayashi, Shiori Honda, Shuichi Sakamoto, (unknown), Hiroki Yoshida, (unknown), Muneaki Hidaka, (unknown), Ken Yasukawa, Yong Kun Park, Masahiko Kurokawa	18
10	Antiviral activity of diarylheptanoid stereoisomers against respiratory syncytial virus in vitro and in vivo 2013 ·Journal of Natural Medicines ·Katsuhiko Konno, Motofumi Miura, Masaharu Toriyama, Shigeyasu Motohashi, Rie Sawamura, Wataru Watanabe, Hiroki Yoshida, Masahiko Katô, Ryuichi Yamamoto, Ken Yasukawa, Masahiko Kurokawa	15
11	Efficacy of Korean traditional medicines against influenza virus infection in mice and their modes of anti-influenza virus action 2011 ·Tomomi Shimizu, Rie Sawamura, Kyung Hwan Kim, (unknown), Seung‐Hun Lee, Yun Seok Lee, (unknown), Hisahiro Kai, Hiroki Yoshida, Wataru Watanabe, Koji Matsuno, Kimíyasu Shiraki, Masahiko Kurokawa	0
12	Efficacy of oral administration of heat-killed probiotics from Mongolian dairy products against influenza infection in mice: Alleviation of influenza infection by its immunomodulatory activity through intestinal immunity 2011 ·International Immunopharmacology ·(unknown), Masahiko Takeshita, Yukiharu Kikuchi, Bumbein Dashnyam, Satoshi Kawahara, Hiroki Yoshida, Wataru Watanabe, Michio Muguruma, Masahiko Kurokawa	86
13	Efficacy of Brazilian Propolis against Herpes Simplex Virus Type 1 Infection in Mice and Their Modes of Antiherpetic Efficacies 2011 ·Evidence-based Complementary and Alternative Medicine ·Tomomi Shimizu, (unknown), Yasushi Takamori, Hisahiro Kai, Rie Sawamura, Hiroki Yoshida, Wataru Watanabe, (unknown), Yong Kun Park, Ken Yasukawa, Koji Matsuno, Kimíyasu Shiraki, Masahiko Kurokawa	50
14	Survey of Community Pharmacists' Attitudes Regarding Involvement in Taking Vital Signs and Performing Emergency Medical Procedures 2010 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·(unknown), Jin Tokunaga, Norito Takamura, Kenji Ogata, Hiroki Yoshida, Masayoshi Koinuma, Hitoshi Nakamura, Keizo Sato	0
15	Vital Sign Monitoring Using Human Patient Simulators at Pharmacy Schools in Japan 2010 ·American Journal of Pharmaceutical Education ·Jin Tokunaga, Norito Takamura, Kenji Ogata, Hiroki Yoshida, (unknown), (unknown), (unknown), (unknown), Keizo Sato	24
16	The citrus flavonoids hesperetin and naringenin block the lipolytic actions of TNF-α in mouse adipocytes 2010 ·Biochemical and Biophysical Research Communications ·Hiroki Yoshida, Norito Takamura, Tsuyoshi Shuto, Kenji Ogata, Jin Tokunaga, Keiichi Kawai, Hirofumi Kai	85
17	Awareness of Hospital Pharmacists with Regard to Expanding the Professional Role of Pharmacists and Analysis of Factors Influencing This 2009 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Jin Tokunaga, Masayoshi Koinuma, Norito Takamura, Kenji Ogata, Hiroki Yoshida, Ryuichi Yamamoto, Hitoshi Nakamura	1
18	Introduction of Pharmaceutical Universal Training Model for Checking Various Administration Routes and Its Evaluation by Students 2008 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Jin Tokunaga, Norito Takamura, Kenji Ogata, Hiroki Yoshida, (unknown), (unknown), (unknown), (unknown)	6
19	Synergistic induction of MUC5AC mucin by nontypeable Haemophilus influenzae and Streptococcus pneumoniae 2007 ·Biochemical and Biophysical Research Communications ·Huahao Shen, Hiroki Yoshida, Fugui Yan, Wen Li, Feng Xu, Huaqiong Huang, Hirofumi Jono, Jiandong Li	27
20	The Tumor Suppressor Cylindromatosis (CYLD) Acts as a Negative Regulator for Toll-like Receptor 2 Signaling via Negative Cross-talk with TRAF6 and TRAF7 2005 ·Journal of Biological Chemistry ·Hiroki Yoshida, Hirofumi Jono, Hirofumi Kai, Jiandong Li	160

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact